Spain (ES)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

On the magnetic properties of iron nanostructures fabricated via focused electron beam induced deposition and autocatalytic growth processes (2016) TU F, Drost M, Vollnhals F, Späth A, Carrasco E, Fink R, Marbach H Journal article Optimizing CuO p-type dye-sensitized solar cells by using a comprehensive electrochemical impedance spectroscopic study (2016) Langmar O, Ganivet CR, De La Torre G, Torres T, Costa RD, Guldi DM Journal article Steering the formation of supported Pt-Sn nanoalloys by reactive metal-oxide interaction (2016) Neitzel A, Kovacs G, Lykhach Y, Tsud N, Kozlov SM, Skala T, Vorokhta M, et al. Journal article Conodonts from the Lower Ordovician of Morocco – a contribution to the faunal diversity in the famous Fezouata Lagerstätte (2016) Lehnert O, Nowak H, Sarmiento G, Servais T, Gutiérrez-Marco JC, Akodad M Journal article Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials (2016) Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al. Conference contribution Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (2016) Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, et al. Conference contribution Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials (2016) Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al. Conference contribution APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS (2016) Gladman DD, Kavanaugh A, Adebajo AO, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials (2016) Gladman D, Kavanaugh A, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution Mechanical behaviour of novel sintered Co-Al-W alloys at high temperatures (2016) Cartón-Cordero M, Campos M, Freund L, Kolb M, Neumeier S, Göken M, Torralba JM Conference contribution, Conference Contribution